SPOTLIGHT -
EP. 1: Introduction: The AUA PSA Screening Guidelines
EP. 2: Melbourne Consensus Statement on PSA Screening
EP. 3: Case Study: Prostate Cancer Screening
EP. 4: Multiparametric MRI for Prostate Cancer Diagnosis
EP. 5: 3D Transperineal Prostate Mapping Biopsies
EP. 6: Treating High-Risk Localized Prostate Cancer
EP. 7: Optimizing ADT in High-Risk Prostate Cancer
EP. 8: LHRH Agonists Versus Antagonists in Prostate Cancer
EP. 9: Intermittent Versus Continuous ADT in Prostate Cancer
EP. 10: Preventing Skeletal-Related Events in Prostate Cancer
EP. 11: Prechemotherapy Treatment Strategies in CRPC
EP. 12: Early Detection of Metastatic Prostate Cancer
EP. 13: Radium-223 in CRPC With Bone Metastases
EP. 14: Multidisciplinary Prostate Cancer Care
EP. 15: AR-Targeted Therapies in Advanced Prostate Cancer
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
